Physician profile
Raj Bhatia
NPI 1447281704
$2,199.71
in general payments reported to CMS, 2019-2025
22 companies · $639 in 2025
The $639 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $95.53 · 2021: $214 · 2022: $206 · 2023: $463 · 2024: $157 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906 · Gift: $203 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.80 |
| Gift | $202.50 |
| Education | $149.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $356.29 | 2023 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $347.45 | 2020-2025 | Nucala, Trelegy Ellipta |
| Jazz Pharmaceuticals INC. | $236.26 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $190.49 | 2019-2024 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $177.51 | 2021-2023 | Fasenra |
| Insmed, INC. | $164.62 | 2021-2025 | Arikayce, Brinsupri |
| Harmony Biosciences LLC | $164.29 | 2020-2023 | Wakix |
| Inspire Medical Systems, INC. | $160.21 | 2019-2024 | Inspire |
| Medical Graphics Corporation | $57.25 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.54 | 2022-2024 | Glassia |
| Lilly USA, LLC | $49.16 | 2025 | Zepbound |
| Philips North America LLC | $43.29 | 2022-2023 | |
| Avadel Cns Pharmaceuticals, LLC | $39.77 | 2025 | Lumryz |
| Axsome Therapeutics, INC. | $38.74 | 2025 | Sunosi |
| Baxter Healthcare | $24.93 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $23.68 | 2021 | |
| Livanova USA, INC. | $19.77 | 2022 | |
| Tactile Systems Technology INC | $16.04 | 2022 | |
| Pfizer INC. | $14.39 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.18 | 2019 | |
| Gilead Sciences, INC. | $10.85 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Bhatia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.